Cervical screening rates for women vaccinated against human papillomavirus

Budd, Alison; Brotherton, Julia; Gertig, Dorota M.; Chau, Theresa; Drennan, Kelly T.; Saville, Marion

doi:10.5694/mja14.00021

Cited by 40 publications

(42 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings of higher Pap testing among women receiving HPV vaccination were similar to a previous study in the U.S. [6] and a study from the U.K. [26] but not consistent with the results of an Australian study [27]. Both the U.K. and Australia have had national programs focused on HPV catch-up vaccination while there has been no comparable program in the U.S. Additionally, variation between our study and the Australian study could be due to differences in study design as their study used linked data with unknown matching sensitivity and they did not account for race/ ethnicity or any socioeconomic factors [27].…”

Section: Resultssupporting

confidence: 64%

“…Both the U.K. and Australia have had national programs focused on HPV catch-up vaccination while there has been no comparable program in the U.S. Additionally, variation between our study and the Australian study could be due to differences in study design as their study used linked data with unknown matching sensitivity and they did not account for race/ ethnicity or any socioeconomic factors [27].…”

Section: Resultscontrasting

confidence: 49%

“…Given that younger women were closer to the recommended age for routine HPV vaccination [13] and older women may have had a pre-established routine of Pap testing, we accounted for age (21)(22)(23)(24)(25)(26)(27)(28)(29)(30). We defined race/ethnicity as four categories: non-Hispanic [NH] White, NH Black, Hispanic, Asian/NH other (89.3% Asian).…”

Section: Covariatesmentioning

confidence: 99%

See 2 more Smart Citations

Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Sauer

Jemal

Fedewa

2015

Cancer Epidemiology

View full text Add to dashboard Cite

Section: Resultssupporting

confidence: 64%

Section: Resultscontrasting

confidence: 49%

Section: Covariatesmentioning

confidence: 99%

See 1 more Smart Citation

Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Sauer

Jemal

Fedewa

2015

Cancer Epidemiology

View full text Add to dashboard Cite

“…This is in contrast to 2 studies in adults, which demonstrated that greater than 90% of participants reported high intention to receive a Pap test after vaccination. 3,4 Our results, combined with another finding in a study of 20-29 year-old women which demonstrated that vaccinated women are less likely to participate in screening compared to unvaccinated women, 5 suggest that educational messages given at the time of HPV vaccination and at followup visits should focus on the importance of following future Pap screening recommendations.…”

Section: Discussionmentioning

confidence: 57%

“…Although two studies in adults demonstrated high intention to participate in Pap screening after vaccination, 3,4 a study in 20-29 year-old women in Australia demonstrated that vaccinated vs. unvaccinated women were less likely to participate in screening. 5 Intention is defined as an individual's motivation to perform a behavior. 6 Self-efficacy is defined as confidence in oneself to exert personal control to perform a behavior.…”

Section: Introductionmentioning

confidence: 99%

Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine

Higgins

Dirksing

Ding

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Human papillomavirus (HPV) vaccines are recommended in the US for girls and women 11-26 y of age. Because these vaccines do not prevent all cervical cancers, Papanicolaou (Pap) screening is still recommended after vaccination. Young women who have been vaccinated may perceive themselves at lower risk for HPV infection and cervical cancer, which could lead to lower intention and self-efficacy to follow cervical cancer screening guidelines, and subsequent nonadherence to Pap testing. The aim of this study was to examine whether perceived risk of human papillomavirus (HPV) after vaccination and other factors are associated with adolescents' intention and self-efficacy to get Pap testing after HPV vaccination. Women 13-21 y of age (N D 339) receiving their first HPV vaccine dose completed a survey. Multivariable logistic regression examined associations between perceived risk of HPV and intention/selfefficacy to get a Pap test while adjusting for other factors. Approximately half of participants reported high intention and half reported high self-efficacy to get a Pap test. Factors significantly associated with high intention were Pap testing history and knowledge about HPV/HPV vaccines; factors significantly associated with high self-efficacy included insurance plan, Pap testing history, communication with clinician about needing a Pap test after vaccination, lifetime number of male sexual partners, and recent smoking. In conclusion, educating adolescents about HPV/HPV vaccines and the need for Pap testing may increase self-efficacy/intention to get a Pap test after vaccination.

show abstract

The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)

Whop

Garvey

Baade

et al. 2016

Cancer

View full text Add to dashboard Cite

BACKGROUNDThe Australian National Cervical Screening Program, introduced more than 20 years ago, does not record the Indigenous status of screening participants. This article reports the first population‐based estimates of participation in cervical screening for Indigenous and non‐Indigenous Australian women.METHODSThis was a retrospective, population‐based study of 1,334,795 female Queensland residents, aged 20 to 69 years, who participated in cervical screening from 2000 to 2011; 26,829 were identified as Indigenous through linkage to hospitalization records. Participation rates were calculated as the number of women screened divided by the average estimated resident population, with adjustments made for hysterectomies, for each 2‐, 3‐, and 5‐year screening period. Multivariate logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs), which were adjusted for age group, place of residence, and socioeconomic disadvantage.RESULTSIn 2010‐2011, the 2‐year participation rate was 55.7% (95% CI, 55.6%‐55.9%) for non‐Indigenous women and 33.5% (95% CI, 32.9%‐34.1%) for Indigenous women; this represented a decrease from 2000‐2001 (57.7% [95% CI, 57.6%‐57.9%] and 35.3% [95% CI, 34.5%‐36.1%], respectively). The difference between Indigenous and non‐Indigenous women was greatest for those aged 45 to 49 years. The 3‐ and 5‐year participation rates were higher within both groups, and the absolute differences between the 2 groups were larger. Significant interactions between the Indigenous status and the place of residence and socioeconomic disadvantage highlight that the Indigenous/non‐Indigenous differential was evident in all places of residence except for very remote areas (OR, 0.99; 95% CI, 0.95‐1.02) and was greatest in the most affluent areas (OR, 0.26; 95% CI, 0.24‐0.27).CONCLUSIONSIndigenous Australian women participate less than non‐Indigenous women, and this gap has not closed. These results provide important benchmarks for the new Australian cervical screening program commencing in 2017, which will provide opportunities to reduce inequities for Indigenous women and address longstanding data deficiencies in the collection of the Indigenous status. Cancer 2016;122:1560–9. © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

show abstract

Cervical screening rates for women vaccinated against human papillomavirus

Cited by 40 publications

References 9 publications

Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine

The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)

Contact Info

Product

Resources

About